VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
WELL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
WELLWelltower Inc.
$229.94$165.7B
Overview & Tools
OverviewChart Terminal ↗AnalysisVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksWELLAnalysis
WELL logo

Welltower Inc. (WELL) Research Brief

Wall Street consensus, price target range, and equity research thesis

Buy35 Analyst Coverage
Consensus Target
$258+12.4% Upside
Current: $229.94
Analyst Range
Low $226High $275
12-Month High/Low Spread
Ratings Mix
25 Buy·10 Hold·0 Sell
Earnings & Valuation
EPS Miss 1.1%
Forward P/E: 81.0x

Executive Summary & Research Take

Wall Street currently rates WELL buy with a 12-month price target of $258 (+12.4% upside). The sections below cover the bull case, key risks, and latest earnings context for Welltower Inc..

Analyst ratings update weekly. Get WELL's next verdict in your inbox.

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

Analyst Research Summary

Investment Thesis: Bull Case & Risk Factors

A structured look at the bull case, the risks, and the most recent earnings execution for WELL.

Current setup

WELL missed estimates last quarter. Below are the key reasons analysts remain constructive and the risks that could change that view.

Bull Case

What keeps the long thesis intact

  • Strong Fundamentals and GrowthWelltower is a top-tier REIT with robust FFO growth and disciplined capital allocation, particularly in its senior housing operating segment.
  • Demographic TailwindsThe aging baby boomer population is a significant demand driver for senior housing, positioning Welltower favorably.
  • Investment Pace and GuidanceWelltower is accelerating its investment pace and has raised its 2026 guidance for normalized FFO, anticipating continued strong performance.
  • Technical IndicatorsTechnical indicators show a bullish trend, with momentum indicators above zero and moving averages crossing bullishly.
  • Analyst ConsensusWall Street analysts have a consensus rating of 'Moderate Buy', with most recommending 'Buy' or 'Strong Buy'.

Wall Street rates WELL buy, giving the bull case institutional backing from 35 analysts.

Watch Out For

What can break the setup quickly

  • Valuation ConcernsWelltower is trading at a high P/FFO multiple, significantly above its historical average, suggesting potential overvaluation.
  • Dividend Payout RatioA high dividend payout ratio raises concerns about the sustainability of Welltower's dividend payments.
  • Integration RisksChallenges in integrating recent acquisitions could diminish EBITDA margins amid increasing competition.
  • Executive Compensation ControversyInvestor backlash over the CEO's payout plan raises governance concerns, impacting management incentives.
  • Market VolatilityAs a healthcare REIT, Welltower is sensitive to market volatility, economic uncertainties, and regulatory changes.
  • EBITDA ConcernsThe company has reported disappointing EBITDA losses and revenue reductions in the past, falling short of estimates.

Watch whether new negative commentary on WELL points to these structural risks or is simply reacting to short-term price moves.

WELL Earnings Reaction — What the Last Quarter Showed

Last Quarter

EPS
$0.61 vs $0.62 est.Miss 1.1%
Revenue
$3.5B vs $3.4B est.Beat 4.2%
Consensus & Technical Research Suite
Open WELL Terminal

WELL Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

WELL Stock Overview

Stock snapshot, live price chart, key ratios, and company profile.

View Overview

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

WELL — Frequently Asked Questions

Quick answers to the most common questions about buying WELL stock.

What is the analyst consensus on WELL?
Verdict

WELL has modest upside — analysts rate it "Buy" with a $258 target, implying +12.4% from today's $229.94. This is informational only — verify the data and consider your own risk tolerance before deciding.

What are recent analyst rating changes for WELL?
Timing

Timing depends on your horizon, but the data signals are: consensus rating "Buy" with +12.4% upside to the $258 target.

What is the price target for WELL stock?
Price Target

WELL's consensus 12-month price target is $258, set by 35 Wall Street analysts. The bull case high is $275 and the bear case low is $226. From the current price of $229.94, this implies +12.4% upside.

Is WELL overvalued or undervalued?
Valuation

WELL appears fairly valued — the $258 consensus target is roughly in line with today's $229.94 (+12.4%). It trades at a forward P/E of 81.0x. Targets range from $226 (bear) to $275 (bull), reflecting different assumptions about growth and margins.

What were WELL's latest earnings results?
Earnings

WELL reports next quarter. Earnings-week moves are volatile — historically, analyst targets revise upward after a beat and downward after a miss. The current consensus is "Buy" with a $258 target. Consider position sizing rather than going all-in pre-print.

What is the bull case for WELL?
Coverage

Of 35 analysts covering Welltower Inc. (WELL): 1 Strong Buy, 24 Buy, 10 Hold, 0 Sell, 0 Strong Sell — a "Buy" consensus. The 12-month price target is $258 (range $226–$275). Bullish analysts outnumber bearish by more than 2-to-1.

What are the risks of investing in WELL?
Risks

No analyst currently rates WELL a Sell, but the 10 Hold ratings reflect concerns about valuation, execution risk, or near-term catalysts. See the Bull vs. Risk cards above for the specific theses on Welltower Inc..

Financial Data & Software Notice: VCP Scanner is an educational financial research database and stock screening software platform. VCP Scanner does not generate, recommend, or package trade decisions, buy/sell signals, or personalized investment advice. Consensus ratings and price targets reflect aggregated third-party Wall Street analyst research from public SEC filings. See our Terms of Service and Privacy Policy.